This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Theracosbio, LLC. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations in Pharmaceutical Formulations by Qiuhua Cai
Introduction
Qiuhua Cai is an accomplished inventor based in Shanghai, China. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of innovative drug delivery systems. Her work focuses on improving the pharmacokinetic profiles of medications, which can enhance their therapeutic effectiveness.
Latest Patents
Qiuhua Cai holds 1 patent related to pharmaceutical formulations. Her patent addresses the SGLT2 inhibitor bexagliflozin, proposing that its pharmacokinetic profile can be improved by formulating it as an extended-release tablet. This innovative approach allows for a lower peak plasma concentration while maintaining therapeutic levels over a desired period. Such formulations enable the administration of lower doses without compromising the pharmacological effect, which is a significant advancement in medication management.
Career Highlights
Qiuhua Cai is currently associated with Theracosbio, LLC, where she continues to explore and develop new pharmaceutical technologies. Her expertise in drug formulation has positioned her as a key player in the pharmaceutical industry, contributing to advancements that can lead to better patient outcomes.
Collaborations
Throughout her career, Qiuhua has collaborated with notable colleagues, including Feng Wang and Ankit Shrivastava. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.
Conclusion
Qiuhua Cai's work in pharmaceutical formulations exemplifies the impact of innovative thinking in medicine. Her contributions not only advance drug delivery systems but also enhance the overall effectiveness of treatments for patients.